BIOMAT Database Logo BIOMAT Database Logo

Drug metabolizing enzymes in lymphocytes. 1999

J L Raucy, and M Ingelman-Sundberg, and S Carpenter, and A Rannug, and A Rane, and M Franklin, and M Romkes
The Agouron Institute, La Jolla, CA 92037, USA.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008658 Inactivation, Metabolic Reduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action. It includes those metabolic transformations that make the substance more soluble for faster renal excretion. Detoxication, Drug, Metabolic,Drug Detoxication, Metabolic,Metabolic Detoxication, Drug,Detoxification, Drug, Metabolic,Metabolic Detoxification, Drug,Metabolic Drug Inactivation,Detoxication, Drug Metabolic,Detoxication, Metabolic Drug,Detoxification, Drug Metabolic,Drug Inactivation, Metabolic,Drug Metabolic Detoxication,Drug Metabolic Detoxification,Inactivation, Metabolic Drug,Metabolic Drug Detoxication,Metabolic Inactivation
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D004798 Enzymes Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified. Biocatalyst,Enzyme,Biocatalysts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J L Raucy, and M Ingelman-Sundberg, and S Carpenter, and A Rannug, and A Rane, and M Franklin, and M Romkes
Extrahepatic drug metabolizing enzymes.
January 1999, Journal of biochemical and molecular toxicology,
J L Raucy, and M Ingelman-Sundberg, and S Carpenter, and A Rannug, and A Rane, and M Franklin, and M Romkes
[Human drug metabolizing enzymes. I. Oxidative enzymes].
September 1998, Acta pharmaceutica Hungarica,
J L Raucy, and M Ingelman-Sundberg, and S Carpenter, and A Rannug, and A Rane, and M Franklin, and M Romkes
[Human drug metabolizing enzymes. II. Conjugation enzymes].
September 1998, Acta pharmaceutica Hungarica,
J L Raucy, and M Ingelman-Sundberg, and S Carpenter, and A Rannug, and A Rane, and M Franklin, and M Romkes
Immunohistochemistry of drug-metabolizing enzymes.
September 1995, Biochemical pharmacology,
J L Raucy, and M Ingelman-Sundberg, and S Carpenter, and A Rannug, and A Rane, and M Franklin, and M Romkes
Phase II drug metabolizing enzymes.
June 2010, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia,
J L Raucy, and M Ingelman-Sundberg, and S Carpenter, and A Rannug, and A Rane, and M Franklin, and M Romkes
Survey of drug-metabolizing enzymes.
August 1983, Biochemical Society transactions,
J L Raucy, and M Ingelman-Sundberg, and S Carpenter, and A Rannug, and A Rane, and M Franklin, and M Romkes
Ontogeny of Drug-Metabolizing Enzymes.
January 2021, Methods in molecular biology (Clifton, N.J.),
J L Raucy, and M Ingelman-Sundberg, and S Carpenter, and A Rannug, and A Rane, and M Franklin, and M Romkes
Nutrition and drug-metabolizing enzymes.
November 1977, Clinical pharmacology and therapeutics,
J L Raucy, and M Ingelman-Sundberg, and S Carpenter, and A Rannug, and A Rane, and M Franklin, and M Romkes
Interactions and drug-metabolizing enzymes.
September 1995, American pharmacy,
J L Raucy, and M Ingelman-Sundberg, and S Carpenter, and A Rannug, and A Rane, and M Franklin, and M Romkes
Expression of drug-metabolizing enzymes.
October 1997, Current opinion in biotechnology,
Copied contents to your clipboard!